Method for treating ophthalmic diseases
US6025329A · kind A · utility
2Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 1997 |
| Grant date | Feb 15, 2000 |
| Priority date | — |
| Expiry date | Jul 2, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/8114
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A therapeutic agent for various retinochoroidal diseases such as pigmentary retinal degeneration, retinopathy, maculopathy and retinal detachment is disclosed. The therapeutic agent for ophthalmic diseases according to the present invention comprises as an effective ingredient a retinal pigment epithelial cell growth factor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.